Scientists created a molecular switch that can revert the fate of cancer cells back to a normal state by capturing the moment ...

The dispute over who invented CRISPR-Cas9 (CRISPR), a gene-editing technology awarded the 2020 Nobel Prize in Chemistry, has been one of the most closely watched legal battles in the world of ...

The Center for Pediatric CRISPR Cures will start by creating custom therapies for eight patients with rare immune or metabolic genetic diseases.

New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with implications for a range of other cancers.

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

Illustration of the CRISPR-Cas9 complex, one of the gene-editing tools developed by the Innovative Genomics Institute. The new Center for Pediatric CRISPR Cures will use CRISPR technology to ...

The logic, as seen in the 5th Circuit's 2024 ruling against Villarreal, is very much in keeping with the problem itself.

Supported by $20 million from the Chan Zuckerberg Initiative, the center focuses on treating rare genetic diseases in children, starting with a group of eight kids who will enroll in a clinical ...

The Second Circuit upheld a public nuisance law that allows firearms manufacturers to be held liable for harm caused by the weapons.

The Eighth Circuit appears to have agreed and has vacated the Click-to-Cancel Rule, citing concerns over the FTC’s statutory authority and procedural defaults in the rulemaking process.